Image

    Reduced Prostate Cancer Risk in Patients with Androgenetic Alopecia Using 5-Alpha Reductase Inhibitors: A TriNetX Real-World Cohort Study

    November 2025 in “ Mendeley Data ”
    Chen, Yu-Jen, Liu, Wei Ting, Yang, Chao-Chun

    Preprint — not peer reviewed. This was posted to a preprint server or data repository. It has not been through a journal's review process, and its findings may change or not hold up.

    Studysummary Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on data.mendeley.com →
    Discuss this study in the Community →